Biological functions


Function Type Function ID Description GeneRatio BgRatio pvalue padjust qvalue GeneCount RABCID
KEGG hsa05135 Yersinia infection 48/1759 137/8135 0.0001918 0.003051 0.002202 48 RABC37
KEGG hsa04218 Cellular senescence 53/1759 156/8135 0.0002238 0.003398 0.002452 53 RABC37
KEGG hsa05160 Hepatitis C 53/1759 157/8135 0.0002682 0.003895 0.002811 53 RABC37
KEGG hsa05132 Salmonella infection 77/1759 249/8135 0.000324 0.004509 0.003254 77 RABC37
KEGG hsa05340 Primary immunodeficiency 18/1759 38/8135 0.0003686 0.004924 0.003554 18 RABC37
KEGG hsa05140 Leishmaniasis 30/1759 77/8135 0.0003954 0.00508 0.003666 30 RABC37
KEGG hsa04140 Autophagy - animal 48/1759 141/8135 0.0004124 0.005101 0.003681 48 RABC37
KEGG hsa04650 Natural killer cell mediated cytotoxicity 45/1759 131/8135 0.0004938 0.00589 0.004251 45 RABC37
KEGG hsa04662 B cell receptor signaling pathway 31/1759 82/8135 0.0005886 0.006779 0.004892 31 RABC37
KEGG hsa04620 Toll-like receptor signaling pathway 37/1759 104/8135 0.0007195 0.00801 0.005781 37 RABC37
KEGG hsa05145 Toxoplasmosis 39/1759 112/8135 0.0008467 0.009122 0.006584 39 RABC37
KEGG hsa03420 Nucleotide excision repair 20/1759 47/8135 0.0009937 0.0101 0.007286 20 RABC37
KEGG hsa05142 Chagas disease 36/1759 102/8135 0.0009975 0.0101 0.007286 36 RABC37
KEGG hsa04141 Protein processing in endoplasmic reticulum 39/949 171/8135 0.000024 0.007842 0.007776 39 RABC38
KEGG hsa04120 Ubiquitin mediated proteolysis 33/949 142/8135 0.0000675 0.01104 0.01094 33 RABC38
KEGG hsa05208 Chemical carcinogenesis - reactive oxygen species 72/1364 223/8135 0.00000000623 0.00000207 0.00000151 72 RABC91
KEGG hsa05166 Human T-cell leukemia virus 1 infection 67/1364 222/8135 0.000000378 0.000063 0.000046 67 RABC91
KEGG hsa04660 T cell receptor signaling pathway 36/1364 104/8135 0.00000688 0.0005946 0.0004342 36 RABC91
KEGG hsa05020 Prion disease 74/1364 273/8135 0.00000839 0.0005946 0.0004342 74 RABC91
KEGG hsa05014 Amyotrophic lateral sclerosis 93/1364 364/8135 0.00000893 0.0005946 0.0004342 93 RABC91
KEGG hsa04658 Th1 and Th2 cell differentiation 32/1364 92/8135 0.0000197 0.0009687 0.0007074 32 RABC91
KEGG hsa04010 MAPK signaling pathway 77/1364 294/8135 0.0000211 0.0009687 0.0007074 77 RABC91
KEGG hsa05235 PD-L1 expression and PD-1 checkpoint pathway in cancer 31/1364 89/8135 0.0000256 0.0009687 0.0007074 31 RABC91
KEGG hsa05169 Epstein-Barr virus infection 57/1364 202/8135 0.0000262 0.0009687 0.0007074 57 RABC91
KEGG hsa04932 Non-alcoholic fatty liver disease 46/1364 155/8135 0.0000402 0.001271 0.0009283 46 RABC91
KEGG hsa05012 Parkinson disease 70/1364 266/8135 0.0000422 0.001271 0.0009283 70 RABC91
KEGG hsa04659 Th17 cell differentiation 35/1364 108/8135 0.0000458 0.001271 0.0009283 35 RABC91
KEGG hsa04066 HIF-1 signaling pathway 35/1364 109/8135 0.0000568 0.001325 0.0009676 35 RABC91
KEGG hsa05170 Human immunodeficiency virus 1 infection 58/1364 212/8135 0.0000591 0.001325 0.0009676 58 RABC91
KEGG hsa05415 Diabetic cardiomyopathy 56/1364 203/8135 0.0000615 0.001325 0.0009676 56 RABC91